tiprankstipranks
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
TVRD
Tvardi Therapeutics
RESEARCH TOOLSreports
Want to see TVRD full AI Analyst Report?

Tvardi Therapeutics (TVRD) Financial Statements

2,522 Followers

Tvardi Therapeutics Financial Overview

Tvardi Therapeutics's market cap is currently $32.55M. The company's EPS TTM is $-0.78; its P/E ratio is -1.38; Tvardi Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 7.14M$ 20.97M$ 41.87M$ 23.03M
Gross Profit$ 0.00$ 6.33M$ 14.54M$ 34.35M$ 21.47M
Operating Income$ -26.75M$ -55.78M$ -121.50M$ -87.53M$ -89.08M
EBITDA$ -26.65M$ -62.60M$ -117.65M$ -83.80M$ -86.89M
Net Income$ -18.21M$ -70.87M$ -118.51M$ -85.47M$ -88.44M
Balance Sheet
Cash & Short-Term Investments$ 30.81M$ 37.90M$ 22.92M$ 43.74M$ 167.03M
Total Assets$ 32.07M$ 43.83M$ 27.00M$ 45.10M$ 247.06M
Total Debt$ 201.00K$ 44.45M$ 368.00K$ 2.37M$ 3.67M
Net Debt$ -20.53M$ 6.54M$ -22.55M$ -19.12M$ -9.78M
Total Liabilities$ 11.13M$ 48.42M$ 89.06M$ 90.15M$ 19.53M
Stockholders' Equity$ 20.95M$ -4.59M$ -62.06M$ -45.05M$ 227.52M
Cash Flow
Free Cash Flow$ -23.50M$ -61.96M$ -21.04M$ -17.92M$ -60.13M
Operating Cash Flow$ -23.50M$ -60.92M$ -21.04M$ -17.87M$ -60.09M
Investing Cash Flow$ -10.08M$ 48.74M$ 22.47M$ -22.00M$ -4.75M
Financing Cash Flow$ 22.70M$ -3.60M$ 2.00K$ 4.00K$ 46.61M
Currency in USD

Tvardi Therapeutics Earnings and Revenue History

Income Statement >

Tvardi Therapeutics Debt to Assets

Balance Sheet >

Tvardi Therapeutics Cash Flow

Cash Flow >

Tvardi Therapeutics Forecast EPS vs Actual EPS

Earnings >